FDA backs RSV vaccine for pregnant women
Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc’s (PFE.N) experimental respiratory syncytial virus (RSV) vaccine, boosting its chances of becoming…
